🇺🇸 FDA
Pipeline program

Ad26.COV2.S

CR108871

Phase 1 mab completed

Quick answer

Ad26.COV2.S for Healthy is a Phase 1 program (mab) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen Cilag International NV
Indication
Healthy
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials